3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
41
Breast Neoplasms
40
Lung Neoplasms
25
Carcinoma, Non-Small-Cell Lung
20
Colorectal Neoplasms
19
Uterine Cervical Neoplasms
13
Prostatic Neoplasms
13
Head and Neck Neoplasms
11
Carcinoma, Hepatocellular
11
Pancreatic Neoplasms
10
Melanoma
10
Ovarian Neoplasms
9
Neoplastic Cells, Circulating
7
Myelodysplastic Syndromes
7
Glioma
7
Esophageal Neoplasms
7
Endometrial Neoplasms
7
Brain Neoplasms
7
Sarcoma
6
Multiple Myeloma
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Disease
5
Colonic Neoplasms
5
Uveal Melanoma
4
Skin Neoplasms
4
Neoplasm, Residual
4
Interventions
Bevacizumab
5
Cetuximab
3
palbociclib
2
encorafenib
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
tislelizumab
1
ribociclib
1
repotrectinib
1
olaparib
1
fludarabine
1
durvalumab
1
dostarlimab
1
atezolizumab
1
Tretinoin
1
Stem Cell Transplantation
1
Sirolimus
1
Ramucirumab
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
Oviposition
1
Melphalan
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
Injections
1
Immunotherapy
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Blood Specimen Collection
×
1 year
×
Clear all
No trials found.